About: Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.
Sector: Healthcare
Industry: Medical Devices
Latest price: $1.13 (-9.60%)
CODX NASDAQ Co-Diagnostics, Inc. Common Stock
Co-Diagnostics, Inc. Common Stock share price
CODX price activity
Last Price
$1.130
Change (24hr)
-0.12 USD (-9.60%)
Volume
301.05K
Volume (4w avg)
-
Open
$1.24
Day Range
$1.13 - $1.24
Previous Close
$1.25
Last Trade
13 Oct, 6:32 pm GMT+0
Delayed
13 Oct, 6:32 pm GMT+0
CODX price performance
Delayed
13 Oct, 6:32 pm GMT+0
CODX Market Signals